General MedicationsORALGeneric
TROVAN
TROVAFLOXACIN MESYLATE
Standard Dose
EQ 200MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview TROVAN is listed in Drugs@FDA under application 020759 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient TROVAFLOXACIN MESYLATE Form and strength TABLET;ORAL - EQ 200MG BASE Sponsor PFIZER Submission history Latest submission status date: 2000-05-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview TROVAN is listed in Drugs@FDA under application 020759 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TROVAFLOXACIN MESYLATE Form and strength TABLET;ORAL - EQ 200MG BASE Sponsor PFIZER Submission history Latest submission status date: 2000-05-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.